|
1
|
Organization WH: Global status report on
noncommunicable diseases 2014. World Health Organization; 2014
|
|
2
|
Berkley KJ, Rapkin AJ and Papka RE: The
pains of endometriosis. Science. 308:1587–1589. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Symons LK, Miller JE, Kay VR, Marks RM,
Liblik K, Koti M and Tayade C: The immunopathophysiology of
endometriosis. Trends Mol Med. 24:748–762. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simpson JL, Elias S, Malinak LR and
Buttram VC Jr: Heritable aspects of endometriosis. I. Genetic
studies. Am J Obstet Gynecol. 137:327–331. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maroun P, Cooper MJ, Reid GD and Keirse
MJ: Relevance of gastrointestinal symptoms in endometriosis. Aust N
Z J Obstet Gynaecol. 49:411–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Graaff AA, D'Hooghe TM, Dunselman GA,
Dirksen CD and Hummelshoj L; WERF EndoCost Consortium and Simoens
S: The significant effect of endometriosis on physical, mental and
social wellbeing: Results from an international cross-sectional
survey. Human Reprod. 28:2677–2685. 2013. View Article : Google Scholar
|
|
7
|
Vassilopoulou L, Matalliotakis M, Zervou
MI, Matalliotaki C, Krithinakis K, Matalliotakis I, Spandidos DA
and Goulielmos GN: Defining the genetic profile of endometriosis.
Exp Ther Med. 17:3267–3281. 2019.PubMed/NCBI
|
|
8
|
Vercellini P, Vigano P, Somigliana E and
Fedele L: Endometriosis: Pathogenesis and treatment. Nat Rev
Endocrinol. 10:261–275. 2014. View Article : Google Scholar
|
|
9
|
Matalliotakis M, Zervou MI, Eliopoulos E,
Matalliotaki C, Rahmioglu N, Kalogiannidis I, Zondervan K,
Spandidos DA, Matalliotakis I and Goulielmos GN: The role of IL16
gene polymorphisms in endometriosis. Int J Mol Med. 41:1469–1476.
2018.PubMed/NCBI
|
|
10
|
Santanam N, Song M, Rong R, Murphy AA and
Parthasarathy S: Atherosclerosis, oxidation and endometriosis. Free
Radical Res. 36:1315–1321. 2002. View Article : Google Scholar
|
|
11
|
Kvaskoff M, Mu F, Terry KL, Harris HR,
Poole EM, Farland L and Missmer SA: Endometriosis: A high-risk
population for major chronic diseases? Hum Reprod Update.
21:500–516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shigesi N, Kvaskoff M, Kirtley S, Feng Q,
Fang H, Knight JC, Missmer SA, Rahmioglu N, Zondervan KT and Becker
CM: The association between endometriosis and autoimmune diseases:
A systematic review and meta-analysis. Hum Reprod Update.
25:486–503. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zervou MI, Vlachakis D, Papageorgiou L,
Eliopoulos E and Goulielmos GN: Increased risk of rheumatoid
arthritis in patients with endometriosis: Genetic aspects.
Rheumatology (Oxford). 61:4252–4262. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin Z, Low HY, Chen BS, Huang KS, Zhang Y,
Wang YH, Ye Z and Wei JC: Risk of ankylosing spondylitis in
patients with endometriosis: A population-based retrospective
cohort study. Front Immunol. 13:8779422022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahn SH, Khalaj K, Young SL, Lessey BA,
Koti M and Tayade C: Immune-inflammation gene signatures in
endometriosis patients. Fertility Sterility. 106:1420–1431.e7.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hai-Feng T, Wei W, Yuan-Yuan Y, Jun Z,
Su-Ping G and Hui-Ming L: Association between polymorphisms in
IL-16 genes and coronary heart disease risk. Pakistan J Med Sci.
29:1033–1037. 2013.
|
|
17
|
Rafi U, Ahmad S, Bokhari SS, Iqbal MA, Zia
A, Khan MA and Roohi N: Association of Inflammatory
Markers/Cytokines with cardiovascular risk manifestation in
patients with endometriosis. Mediators Inflamm. 2021:34255602021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kinugasa S, Shinohara K and Wakatsuki A:
Increased asymmetric dimethylarginine and enhanced inflammation are
associated with impaired vascular reactivity in women with
endometriosis. Atherosclerosis. 219:784–788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Melo AS, Rosa-e-Silva JC, Rosa-e-Silva AC,
Poli-Neto OB, Ferriani RA and Vieira CS: Unfavorable lipid profile
in women with endometriosis. Fertil Steril. 93:2433–2436. 2010.
View Article : Google Scholar
|
|
20
|
Mu F, Rich-Edwards J, Rimm EB, Spiegelman
D and Missmer SA: Endometriosis and risk of coronary heart disease.
Circ Cardiovasc Qual Outcomes. 9:257–264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akinjero A, Adegbala O and Akinyemiju T:
Abstract P320: Is Co-occurring endometriosis among women with
myocardial infarction associated with worse In-hospital outcomes?
Findings from the nationwide inpatient sample. Circulation.
135:AP320. 2017. View Article : Google Scholar
|
|
22
|
Chiang HJ, Lan KC, Yang YH, Chiang JY,
Kung FT, Huang FJ, Lin YJ, Su YT and Sung PH: Risk of major adverse
cardiovascular and cerebrovascular events in Taiwanese women with
endometriosis. J Formos Med Assoc. 120:327–336. 2021. View Article : Google Scholar
|
|
23
|
Okoth K, Wang J, Zemedikun D, Thomas GN,
Nirantharakumar K and Adderley NJ: Risk of cardiovascular outcomes
among women with endometriosis in the United Kingdom: A
retrospective matched cohort study. BJOG. 128:1598–1609. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Marchandot B, Curtiaud A, Matsushita K,
Trimaille A, Host A, Faller E, Garbin O, Akladios C, Jesel L and
Morel O: Endometriosis and cardiovascular disease. Eur Heart J
Open. 2:oeac0012022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Benjamin EJ, Muntner P, Alonso A,
Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR,
Cheng S, Das SR, et al: Heart disease and stroke statistics-2019
Update: A report from the american heart association. Circulation.
139:e56–e528. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Samani NJ, Erdmann J, Hall AS,
Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund
P, Wichmann HE, et al: Genomewide association analysis of coronary
artery disease. N Engl J Med. 357:443–453. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McPherson R, Pertsemlidis A, Kavaslar N,
Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA,
Tybjaerg-Hansen A, Folsom AR, et al: A common allele on chromosome
9 associated with coronary heart disease. Science. 316:1488–1491.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Helgadottir A, Thorleifsson G, Manolescu
A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A,
Sigurdsson A, Baker A, Palsson A, et al: A common variant on
chromosome 9p21 affects the risk of myocardial infarction. Science.
316:1491–1493. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wellcome Trust Case Control Consortium:
Genome-wide association study of 14,000 cases of seven common
diseases and 3,000 shared controls. Nature. 447:661–678. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Clarke R, Peden JF, Hopewell JC, Kyriakou
T, Goel A, Heath SC, Parish S, Barlera S, Franzosi MG, Rust S, et
al: Genetic variants associated with Lp(a) lipoprotein level and
coronary disease. N Engl J Med. 361:2518–2528. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Visel A, Zhu Y, May D, Afzal V, Gong E,
Attanasio C, Blow MJ, Cohen JC, Rubin EM and Pennacchio LA:
Targeted deletion of the 9p21 non-coding coronary artery disease
risk interval in mice. Nature. 464:409–412. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Holdt LM and Teupser D: Recent studies of
the human chromosome 9p21 locus, which is associated with
atherosclerosis in human populations. Arterioscler Thromb Vasc
Biol. 32:196–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Holdt LM, Stahringer A, Sass K, Kulak NA,
Wilfert W, Kohlmaier A, Herbst A, Northoff BH, Nicolaou A, Gäbel G,
et al: Circular non-coding RNA ANRIL modulates ribosomal RNA
maturation and atherosclerosis in humans. Nat Commun. 7:124292016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lo Sardo V, Chubukov P, Ferguson W, Kumar
A, Teng EL, Duran M, Zhang L, Cost G, Engler AJ, Urnov F, et al:
Unveiling the role of the most impactful cardiovascular risk locus
through haplotype editing. Cell. 175:1796–1810.20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kessler T and Schunkert H: Coronary artery
disease genetics enlightened by genome-wide association studies.
JACC Basic Transl Sci. 6:610–623. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stortoni P, Cecati M, Giannubilo SR,
Sartini D, Turi A, Emanuelli M and Tranquilli AL: Placental
thrombomodulin expression in recurrent miscarriage. Reprod Biol
Endocrinol. 8:12010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saha R, Pettersson HJ, Svedberg P,
Olovsson M, Bergqvist A, Marions L, Tornvall P and Kuja-Halkola R:
Heritability of endometriosis. Fertil Steril. 104:947–952. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Falconer H, D'Hooghe T and Fried G:
Endometriosis and genetic polymorphisms. Obstet Gynecol Surv.
62:616–628. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rahmioglu N, Montgomery GW and Zondervan
KT: Genetics of endometriosis. Women's Health. 11:577–586. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nyholt DR, Low SK, Anderson CA, Painter
JN, Uno S, Morris AP, MacGregor S, Gordon SD, Henders AK, Martin
NG, et al: Genome-wide association meta-analysis identifies new
endometriosis risk loci. Nat Genet. 44:1355–1359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rahmioglu N, Nyholt DR, Morris AP, Missmer
SA, Montgomery GW and Zondervan KT: Genetic variants underlying
risk of endometriosis: Insights from meta-analysis of eight
genome-wide association and replication datasets. Hum Reprod
Update. 20:702–716. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Uimari O, Rahmioglu N, Nyholt DR, Vincent
K, Missmer SA, Becker C, Morris AP, Montgomery GW and Zondervan KT:
Genome-wide genetic analyses highlight mitogen-activated protein
kinase (MAPK) signaling in the pathogenesis of endometriosis. Hum
Reprod. 32:780–793. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Watanabe K, Taskesen E, van Bochoven A and
Posthuma D: Functional mapping and annotation of genetic
associations with FUMA. Nat Commun. 8:18262017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sapkota Y, Steinthorsdottir V, Morris AP,
Fassbender A, Rahmioglu N, De Vivo I, Buring JE, Zhang F, Edwards
TL, Jones S, et al: Meta-analysis identifies five novel loci
associated with endometriosis highlighting key genes involved in
hormone metabolism. Nat Commun. 8:155392017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sapkota Y, Fassbender A, Bowdler L, Fung
JN, Peterse D, O D, Montgomery GW, Nyholt DR and D'Hooghe TM:
Independent replication and meta-analysis for endometriosis risk
loci. Twin Res Hum Genet. 18:518–525. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rahmioglu N, Mortlock S, Ghiasi M, Møller
PL, Stefansdottir L, Galarneau G, Turman C, Danning R, Law MH,
Sapkota Y, et al: The genetic basis of endometriosis and
comorbidity with other pain and inflammatory conditions. Nat Genet.
In press.
|
|
47
|
Albertsen HM, Matalliotaki C,
Matalliotakis M, Zervou MI, Matalliotakis I, Spandidos DA, Chettier
R, Ward K and Goulielmos GN: Whole exome sequencing identifies
hemizygous deletions in the UGT2B28 and USP17L2 genes in a
threegeneration family with endometriosis. Mol Med Rep.
19:1716–1720. 2019.PubMed/NCBI
|
|
48
|
Libby P: Inflammation in atherosclerosis.
Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Moore KJ and Tabas I: Macrophages in the
pathogenesis of atherosclerosis. Cell. 145:341–355. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Randolph GJ: The fate of monocytes in
atherosclerosis. J Thromb Haemost. 7(Suppl 1): S28–S30. 2009.
View Article : Google Scholar
|
|
51
|
Swirski FK and Nahrendorf M: Leukocyte
behavior in atherosclerosis, myocardial infarction, and heart
failure. Science. 339:161–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ridker PM: Residual inflammatory risk:
Addressing the obverse side of the atherosclerosis prevention coin.
Eur Heart J. 37:1720–1722. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ridker PM, Everett BM, Thuren T, MacFadyen
JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker
SD, et al: Antiinflammatory therapy with canakinumab for
atherosclerotic disease. N Engl J Med. 377:1119–1131. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tardif JC, Kouz S, Waters DD, Bertrand OF,
Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, et al:
Efficacy and safety of low-dose colchicine after myocardial
infarction. N Engl J Med. 381:2497–2505. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nidorf SM, Fiolet ATL, Mosterd A,
Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA,
Lenderink T, et al: Colchicine in patients with chronic coronary
disease. N Engl J Med. 383:1838–1847. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Schloss MJ, Swirski FK and Nahrendorf M:
Modifiable cardiovascular risk, hematopoiesis, and innate immunity.
Circ Res. 126:1242–1259. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Vromman A, Ruvkun V, Shvartz E,
Wojtkiewicz G, Santos Masson G, Tesmenitsky Y, Folco E, Gram H,
Nahrendorf M, Swirski FK, et al: Stage-dependent differential
effects of interleukin-1 isoforms on experimental atherosclerosis.
Eur Heart J. 40:2482–2491. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Grebe A, Hoss F and Latz E: NLRP3
inflammasome and the IL-1 pathway in atherosclerosis. Circ Res.
122:1722–1740. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zernecke A, Shagdarsuren E and Weber C:
Chemokines in atherosclerosis: An update. Arterioscler Thromb Vasc
Biol. 28:1897–1908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Schunkert H, Konig IR, Kathiresan S,
Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M,
Gieger C, et al: Large-scale association analysis identifies 13 new
susceptibility loci for coronary artery disease. Nat Genet.
43:333–338. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
61
|
Doring Y, Noels H, van der Vorst EPC,
Neideck C, Egea V, Drechsler M, Mandl M, Pawig L, Jansen Y,
Schröder K, et al: Vascular CXCR4 limits atherosclerosis by
maintaining arterial integrity: Evidence from mouse and human
studies. Circulation. 136:388–403. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Doring Y, van der Vorst EPC, Duchene J,
Jansen Y, Gencer S, Bidzhekov K, Atzler D, Santovito D, Rader DJ,
Saleheen D and Weber C: CXCL12 derived from endothelial cells
promotes atherosclerosis to drive coronary artery disease.
Circulation. 139:1338–1340. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Pober JS and Sessa WC: Evolving functions
of endothelial cells in inflammation. Nat Rev Immunol. 7:803–815.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Lohse AW, Knolle PA, Bilo K, Uhrig A,
Waldmann C, Ibe M, Schmitt E, Gerken G, Meyer Zum and Büschenfelde
KH: Antigen-presenting function and B7 expression of murine
sinusoidal endothelial cells and Kupffer cells. Gastroenterology.
110:1175–1181. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wedgwood JF, Hatam L and Bonagura VR:
Effect of interferon-gamma and tumor necrosis factor on the
expression of class I and class II major histocompatibility
molecules by cultured human umbilical vein endothelial cells. Cell
Immunol. 111:1–9. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Carman CV and Martinelli R: T
Lymphocyte-endothelial interactions: Emerging understanding of
trafficking and antigen-specific immunity. Front Immunol.
6:6032015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Motz GT, Santoro SP, Wang LP, Garrabrant
T, Lastra RR, Hagemann IS, Lal P, Feldman MD, Benencia F and Coukos
G: Tumor endothelium FasL establishes a selective immune barrier
promoting tolerance in tumors. Nat Med. 20:607–615. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Full LE, Ruisanchez C and Monaco C: The
inextricable link between atherosclerosis and prototypical
inflammatory diseases rheumatoid arthritis and systemic lupus
erythematosus. Arthritis Res Ther. 11:2172009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Glavind MT, Forman A, Arendt LH, Nielsen K
and Henriksen TB: Endometriosis and pregnancy complications: A
Danish cohort study. Fertil Steril. 107:160–166. 2017. View Article : Google Scholar
|
|
70
|
Haney AF, Jenkins S and Weinberg JB: The
stimulus responsible for the peritoneal fluid inflammation observed
in infertile women with endometriosis. Fertil Steril. 56:408–413.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Uz YH, Murk W, Bozkurt I, Kizilay G, Arici
A and Kayisli UA: Increased c-Jun N-terminal kinase activation in
human endometriotic endothelial cells. Histochem Cell Biol.
135:83–91. 2011. View Article : Google Scholar
|
|
72
|
Bedaiwy MA and Falcone T: Peritoneal fluid
environment in endometriosis. Clinicopathological implications.
Minerva Ginecol. 55:333–345. 2003.PubMed/NCBI
|
|
73
|
Agic A, Xu H, Finas D, Banz C, Diedrich K
and Hornung D: Is endometriosis associated with systemic
subclinical inflammation? Gynecol Obstet Invest. 62:139–147. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Monsanto SP, Edwards AK, Zhou J,
Nagarkatti P, Nagarkatti M, Young SL, Lessey BA and Tayade C:
Surgical removal of endometriotic lesions alters local and systemic
proinflammatory cytokines in endometriosis patients. Fertil Steril.
105:968–977.e965. 2016. View Article : Google Scholar :
|
|
75
|
Graziottin A, Skaper SD and Fusco M: Mast
cells in chronic inflammation, pelvic pain and depression in women.
Gynecol Endocrinol. 30:472–477. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Indraccolo U and Barbieri F: Effect of
palmitoylethanolamide-polydatin combination on chronic pelvic pain
associated with endometriosis: Preliminary observations. Eur J
Obstet Gynecol Reprod Biol. 150:76–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Grandi G, Mueller MD, Papadia A, Kocbek V,
Bersinger NA, Petraglia F, Cagnacci A and McKinnon B: Inflammation
influences steroid hormone receptors targeted by progestins in
endometrial stromal cells from women with endometriosis. J Reprod
Immunol. 117:30–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Garcia-Gomez E, Vazquez-Martinez ER,
Reyes-Mayoral C, Cruz-Orozco OP, Camacho-Arroyo I and Cerbon M:
Regulation of Inflammation Pathways and Inflammasome by Sex Steroid
Hormones in Endometriosis. Front Endocrinol. 10:9352019. View Article : Google Scholar
|
|
79
|
Bao C, Wang H and Fang H: Genomic evidence
supports the recognition of endometriosis as an inflammatory
systemic disease and reveals disease-specific therapeutic
potentials of targeting neutrophil degranulation. Front Immunol.
13:7584402022. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Malhotra N, Karmakar D, Tripathi V, Luthra
K and Kumar S: Correlation of angiogenic cytokines-leptin and IL-8
in stage, type and presentation of endometriosis. Gynecol
Endocrinol. 28:224–227. 2012. View Article : Google Scholar
|
|
81
|
Kobayashi H, Higashiura Y, Shigetomi H and
Kajihara H: Pathogenesis of endometriosis: The role of initial
infection and subsequent sterile inflammation (Review). Mol Med
Rep. 9:9–15. 2014. View Article : Google Scholar
|
|
82
|
Shifren JL, Tseng JF, Zaloudek CJ, Ryan
IP, Meng YG, Ferrara N, Jaffe RB and Taylor RN: Ovarian steroid
regulation of vascular endothelial growth factor in the human
endometrium: implications for angiogenesis during the menstrual
cycle and in the pathogenesis of endometriosis. J Clin Endocrinol
Metab. 81:3112–3118. 1996.PubMed/NCBI
|
|
83
|
Kirchhoff D, Kaulfuss S, Fuhrmann U,
Maurer M and Zollner TM: Mast cells in endometriosis: Guilty or
innocent bystanders? Expert Opin Ther Targets. 16:237–241. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Wu J, Xie H, Yao S and Liang Y: Macrophage
and nerve interaction in endometriosis. J Neuroinflammation.
14:532017. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Sasamoto N, Ngo L, Vitonis AF, Dillon ST,
Missmer SA, Libermann TA and Terry KL: Circulating proteomic
profiles associated with endometriosis in adolescents and young
adults. Hum Reprod. 37:2042–2053. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Ahmed Z and Bicknell R: Angiogenic
signalling pathways. Methods Mol Biol. 467:3–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Landskroner-Eiger S, Moneke I and Sessa
WC: miRNAs as modulators of angiogenesis. Cold Spring Harb Perspect
Med. 3:a0066432013. View Article : Google Scholar
|
|
88
|
Wang S and Olson EN: AngiomiRs-key
regulators of angiogenesis. Curr Opin Genet Dev. 19:205–211. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Uchida S and Dimmeler S: Long noncoding
RNAs in cardiovascular diseases. Circ Res. 116:737–750. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kumar MM and Goyal R: LncRNA as a
therapeutic target for angiogenesis. Curr Top Med Chem.
17:1750–1757. 2017. View Article : Google Scholar :
|
|
91
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Michel JB, Thaunat O, Houard X, Meilhac O,
Caligiuri G and Nicoletti A: Topological determinants and
consequences of adventitial responses to arterial wall injury.
Arterioscler Thromb Vasc Biol. 27:1259–1268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Moreno PR, Purushothaman KR, Sirol M, Levy
AP and Fuster V: Neovascularization in human atherosclerosis.
Circulation. 113:2245–2252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Conway EM, Collen D and Carmeliet P:
Molecular mechanisms of blood vessel growth. Cardiovasc Res.
49:507–521. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Simons M: Angiogenesis: Where do we stand
now? Circulation. 111:1556–1566. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Tanaka K, Nagata D, Hirata Y, Tabata Y,
Nagai R and Sata M: Augmented angiogenesis in adventitia promotes
growth of atherosclerotic plaque in apolipoprotein E-deficient
mice. Atherosclerosis. 215:366–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Carmeliet P: Angiogenesis in health and
disease. Nat Med. 9:653–660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Michel JB, Martin-Ventura JL, Nicoletti A
and Ho-Tin-Noe B: Pathology of human plaque vulnerability:
Mechanisms and consequences of intraplaque haemorrhages.
Atherosclerosis. 234:311–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Bhardwaj S, Roy H, Heikura T and
Yla-Herttuala S: VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced
intimal hyperplasia in carotid arteries. Eur J Clin Invest.
35:669–676. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Moulton KS, Heller E, Konerding MA, Flynn
E, Palinski W and Folkman J: Angiogenesis inhibitors endostatin or
TNP-470 reduce intimal neovascularization and plaque growth in
apolipoprotein E-deficient mice. Circulation. 99:1726–1732. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Swirski FK and Nahrendorf M:
Cardioimmunology: The immune system in cardiac homeostasis and
disease. Nat Rev Immunolo. 18:733–744. 2018. View Article : Google Scholar
|
|
102
|
Dang TA, Schunkert H and Kessler T: cGMP
signaling in cardiovascular diseases: Linking genotype and
phenotype. J Cardiovasc Pharmacol. 75:516–525. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Feil R and Kemp-Harper B: cGMP signalling:
From bench to bedside. Conference on cGMP generators, effectors and
therapeutic implications. EMBO Rep. 7:149–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Dubey RK, Jackson EK and Luscher TF:
Nitric oxide inhibits angiotensin II-induced migration of rat
aortic smooth muscle cell. Role of cyclic-nucleotides and
angiotensin1 receptors. J Clin Invest. 96:141–149. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Taylor HS, Kotlyar AM and Flores VA:
Endometriosis is a chronic systemic disease: Clinical challenges
and novel innovations. Lancet. 397:839–852. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Bacci M, Capobianco A, Monno A, Cottone L,
Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S,
et al: Macrophages are alternatively activated in patients with
endometriosis and required for growth and vascularization of
lesions in a mouse model of disease. Am J Pathol. 175:547–556.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Bianco B, André GM, Vilarino FL, Peluso C,
Mafra FA, Christofolini DM and Barbosa CP: The possible role of
genetic variants in autoimmune-related genes in the development of
endometriosis. Hum Immunol. 73:306–315. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Liu D, Song J, Ji X, Liu Z, Cong M and Hu
B: Association of genetic polymorphisms on VEGFA and VEGFR2 with
risk of coronary heart disease. Medicine. 95:e34132016. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Ma H, Marti-Gutierrez N, Park SW, Wu J,
Hayama T, Darby H, Van Dyken C, Li Y, Koski A, Liang D, Ma, et al:
reply. Nature. 560:E10–E23. 2018. View Article : Google Scholar
|
|
111
|
Shimizu Y, Arima K, Noguchi Y, Yamanashi
H, Kawashiri SY, Nobusue K, Nonaka F, Aoyagi K, Nagata Y and Maeda
T: Vascular endothelial growth factor (VEGF) polymorphism rs3025039
and atherosclerosis among older with hypertension. Sci Rep.
12:55642022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Eldafira E, Prasasty VD, Abinawanto A,
Syahfirdi L and Pujianto DA: Polymorphisms of estrogen receptor-α
and estrogen receptor-β genes and its expression in endometriosis.
Turk J Pharm Sci. 18:91–95. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Casazza K, Page GP and Fernandez JR: The
association between the rs2234693 and rs9340799 estrogen receptor
alpha gene polymorphisms and risk factors for cardiovascular
disease: A review. Biol Res Nurs. 12:84–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Mao T, Zong LL, Wang YF, Zhao X, Fu YG,
Zeng J and Rao XQ: Association of the IL-6 gene 634C/G polymorphism
with susceptibility to endometriosis. Zhonghua Yi Xue Yi Chuan Xue
Za Zhi. 28:555–558. 2011.In Chinese. PubMed/NCBI
|
|
115
|
Lu S, Wang Y, Wang Y, Hu J, Di W, Liu S,
Zeng X, Yu G, Wang Y and Wang Z: The IL-6 rs1800795 and rs1800796
polymorphisms are associated with coronary artery disease risk. J
Cell Mol Med. 24:6191–6207. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Kumari R and Kumar S, Ahmad MK, Singh R,
Kant Kumar S, Pradhan A, Chandra S and Kumar S: Promoter variants
of TNF-α rs1800629 and IL-10 rs1800871 are independently associated
with the susceptibility of coronary artery disease in north Indian.
Cytokine. 110:131–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Juo SH, Wu R, Lin CS, Wu MT, Lee JN and
Tsai EM: A functional promoter polymorphism in interleukin-10 gene
influences susceptibility to endometriosis. Fertil Steril.
92:1228–1233. 2009. View Article : Google Scholar
|
|
118
|
Zheng J, Chen T and Lin H: IL-10, IL-18
gene polymorphisms might influence predisposition to coronary
artery disease in east asians: A meta-analysis. Immunol Invest.
50:37–46. 2021. View Article : Google Scholar
|
|
119
|
Chen Y, Huang H, Liu S, Pan LA, Zhou B,
Zhang L and Zeng Z: IL-16 rs11556218 gene polymorphism is
associated with coronary artery disease in the Chinese Han
population. Clin Biochem. 44:1041–1044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Luo Z, Lu Z, Muhammad I, Chen Y, Chen Q,
Zhang J and Song Y: Associations of the MTHFR rs1801133
polymorphism with coronary artery disease and lipid levels: A
systematic review and updated meta-analysis. Lipids Health Dis.
17:1912018. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Szczepanska M, Mostowska A, Wirstlein P,
Lianeri M, Marianowski P, Skrzypczak J and Jagodziński PP:
Polymorphic variants of folate and choline metabolism genes and the
risk of endometriosis-associated infertility. Eur J Obstet Gynecol
Reprod Biol. 157:67–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Rodriguez-Rodriguez L, Lopez-Mejias R,
Garcia-Bermudez M, Gonzalez-Juanatey C, Gonzalez-Gay MA and Martin
J: Genetic markers of cardiovascular disease in rheumatoid
arthritis. Mediators Inflamm. 2012:5748172012. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Sundqvist J, Falconer H, Seddighzadeh M,
Vodolazkaia A, Fassbender A, Kyama C, Bokor A, Stephansson O,
Padyukov L, Gemzell-Danielsson K and D'Hooghe TM: Endometriosis and
autoimmune disease: Association of susceptibility to
moderate/severe endometriosis with CCL21 and HLA-DRB1. Fertil
Steril. 95:437–440. 2011. View Article : Google Scholar
|
|
124
|
Nilufer R, Karina B, Paraskevi C, Rebecca
D, Genevieve G, Ayush G, Stuar M, Sally M, Yadav S, Andrew SJ, et
al: Large-scale genome-wide association meta-analysis of
endometriosis reveals 13 novel loci and genetically-associated
comorbidity with other pain conditions. bio Rxiv. 406967. 2018,
View Article : Google Scholar
|
|
125
|
Zhang H, Mooney CJ and Reilly MP: ABO
blood groups and cardiovascular diseases. Int J Vasc Med.
2012:6419172012.PubMed/NCBI
|
|
126
|
Omrani-Nava V, Hedayatizadeh-Omran A,
Alizadeh-Navaei R, Mokhberi V, Jalalian R, Janbabaei G, Amjadi O,
Rahmatpour G and Mozaffari A: TP53 single nucleotide polymorphism
(rs1042522) in Iranian patients with coronary artery disease.
Biomed Rep. 9:259–265. 2018.PubMed/NCBI
|
|
127
|
Li J, Chen Y, Mo Z and Li L: TP53 Arg72Pro
polymorphism (rs1042522) and risk of endometriosis among Asian and
Caucasian populations. Eur J Obstet Gynecol Reprod Biol. 189:73–78.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Shakhtshneider E, Orlov P, Semaev S,
Ivanoshchuk D, Malyutina S, Gafarov V, Ragino Y and Voevoda M:
Analysis of polymorphism rs1333049 (Located at 9P21.3) in the white
population of western siberia and associations with clinical and
biochemical markers. Biomolecules. 9:2902019. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Lalami I, Abo C, Borghese B, Chapron C and
Vaiman D: Genomics of endometriosis: From genome wide association
studies to exome sequencing. Int J Mol Sci. 22:72972021. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Kang YJ, Jeung IC, Park A, Park YJ, Jung
H, Kim TD, Lee HG, Choi I and Yoon SR: An increased level of IL-6
suppresses NK cell activity in peritoneal fluid of patients with
endometriosis via regulation of SHP-2 expression. Hum Reprod.
29:2176–2189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Holdt LM and Teupser D: Long noncoding RNA
ANRIL: Lnc-ing genetic variation at the chromosome 9p21 locus to
molecular mechanisms of atherosclerosis. Front Cardiovasc Med.
5:1452018. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Matoo S, Fallah MS, Daneshpour MS, Mousavi
R, Sedaghati Khayat B, Hasanzad M and Azizi F: Increased risk of
CHD in the presence of rs7865618 (A allele): Tehran lipid and
glucose study. Arch Iran Med. 20:153–157. 2017.PubMed/NCBI
|
|
133
|
Manjula G, Pranavchand R, Kumuda I, Reddy
BS and Reddy BM: The SNP rs7865618 of 9p213 locus emerges as the
most promising marker of coronary artery disease in the southern
Indian population. Sci Rep. 10:215112020. View Article : Google Scholar
|
|
134
|
Yang Y, Shi X, Du Z, Zhou G and Zhang X:
Associations between genetic variations in microRNA and myocardial
infarction susceptibility: A meta-analysis and systematic review.
Herz. 47:524–535. 2022. View Article : Google Scholar
|
|
135
|
Farsimadan M, Ismail Haje M, Khudhur
Mawlood C, Arabipour I, Emamvirdizadeh A, Takamoli S, Masumi M and
Vaziri H: MicroRNA variants in endometriosis and its severity. Br J
Biomed Sci. 78:206–210. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Cai MY, Cheng J, Zhou MY, Liang LL, Lian
SM, Xie XS, Xu S, Liu X and Xiong XD: The associationbetween
pre-miR-27a rs 895819 polymorphism and myocardial infarction risk
in a Chinese Han population. Lipids Health Dis. 17:72018.
View Article : Google Scholar
|
|
137
|
Jaafar SO, Jaffar JO, Ibrahim SA and
Jarjees KK: MicroRNA Variants miR-27a rs895819 and miR-423
rs6505162, but not miR-124-1 rs531564, are Linked to endometriosis
and its severity. Br J Biomed Sci. 79:102072022. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Zhang Z, Li H, Zhao Z, Gao B, Meng L and
Feng X: miR-146b level and variants is associated with
endometriosis related macrophages phenotype and plays a pivotal
role in the endometriotic pain symptom. Taiwan J Obstet Gynecol.
58:401–408. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Zhao Y, Ponnusamy M, Zhang L, Zhang Y, Liu
C, Yu W, Wang K and Li P: The role of miR-214 in cardiovascular
diseases. Eur J Pharmacol. 816:138–145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Jones Buie JN, Goodwin AJ, Cook JA,
Halushka PV and Fan H: The role of miRNAs in cardiovascular disease
risk factors. Atherosclerosis. 254:271–281. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
CARDIoGRAMplusC4D Consortium; Deloukas P,
Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR,
Ingelsson E, Saleheen D, Erdmann J, et al: Large-scale association
analysis identifies new risk loci for coronary artery disease. Nat
Genet. 45:25–33. 2013. View Article : Google Scholar
|
|
142
|
Ghafouri-Fard S, Shoorei H and Taheri M:
Role of Non-coding RNAs in the pathogenesis of endometriosis. Front
Oncol. 10:13702020. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Besseling J, Hovingh GK, Huijgen R,
Kastelein JJP and Hutten BA: Statins in familial
hypercholesterolemia: Consequences for coronary artery disease and
All-cause mortality. J Am Coll Cardiol. 68:252–260. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Jha CK, Mir R, Elfaki I, Khullar N, Rehman
S, Javid J, Banu S and Chahal SMS: Potential impact of MicroRNA-423
gene variability in coronary artery disease. Endocr Metab Immune
Disord Drug Targets. 19:67–74. 2019. View Article : Google Scholar
|
|
145
|
Chang CY, Lai MT, Chen Y, Yang CW, Chang
HW, Lu CC, Chen CM, Chan C, Chung C, Tseng CC, et al: Up-regulation
of ribosome biogenesis by MIR196A2 genetic variation promotes
endometriosis development and progression. Oncotarget.
7:76713–76725. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Fragoso JM, Ramirez-Bello J, Martinez-Rios
MA, Peña-Duque MA, Posadas-Sánchez R, Delgadillo-Rodríguez H,
Jiménez-Morales M, Posadas-Romero C and Vargas-Alarcón G: miR-196a2
(rs11614913) polymorphism is associated with coronary artery
disease, but not with in-stent coronary restenosis. Inflamm Res.
68:215–221. 2019. View Article : Google Scholar
|
|
147
|
Davignon J: Beneficial cardiovascular
pleiotropic effects of statins. Circulation. 109(23 Suppl 1):
III39–II43. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Leuschner F, Rauch PJ, Ueno T, Gorbatov R,
Marinelli B, Lee WW, Dutta P, Wei Y, Robbins C, Iwamoto Y, et al:
Rapid monocyte kinetics in acute myocardial infarction are
sustained by extramedullary monocytopoiesis. J Exp Med.
209:123–137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Hoyer FF, Naxerova K, Schloss MJ, Hulsmans
M, Nair AV, Dutta P, Calcagno DM, Herisson F, Anzai A, Sun Y, et
al: Tissue-specific macrophage responses to remote injury impact
the outcome of subsequent local immune challenge. Immunity.
51:899–914 e897. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Burney RO and Giudice LC: Pathogenesis and
pathophysiology of endometriosis. Fertil Steril. 98:511–519. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Zhao N and Zhang J: Role of alternative
splicing of VEGF-A in the development of atherosclerosis. Aging.
10:2695–2708. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Zhao W, Li Y, Zhao J and Kang S: A
functional promoter polymorphism in interleukin 12B gene is
associated with an increased risk of ovarian endometriosis. Gene.
666:27–31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Buroker NE: SNP (rs1570360) in
transcriptional factor binding sites of the VEGFA promoter is
associated with hypertensive nephropathy and diabetic retinopathy.
Austin J Endocrinol Diabetes. 2:1–5. 2015.
|
|
154
|
Kim I, Moon SO, Kim SH, Kim HJ, Koh YS and
Koh GY: Vascular endothelial growth factor expression of
intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion
molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B
activation in endothelial cells. J Biol Chem. 276:7614–7620. 2001.
View Article : Google Scholar
|
|
155
|
McCarron SL, Edwards S, Evans PR, Gibbs R,
Dearnaley DP, Dowe A, Southgate C, Easton DF, Eeles RA and Howell
WM: Influence of cytokine gene polymorphisms on the development of
prostate cancer. Cancer Res. 62:3369–3372. 2002.PubMed/NCBI
|
|
156
|
Howell WM, Bateman AC, Turner SJ, Collins
A and Theaker JM: Influence of vascular endothelial growth factor
single nucleotide polymorphisms on tumour development in cutaneous
malignant melanoma. Genes Immunity. 3:229–232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Vigano P, Parazzini F, Somigliana E and
Vercellini P: Endometriosis: Epidemiology and aetiological factors.
Best Pract Res Clin Obstet Gynaecol. 18:177–200. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Wang W, Xu A and Xu H: The roles of
vascular endothelial growth factor gene polymorphisms in congenital
heart diseases: A meta-analysis. Growth Factors. 36:232–238. 2018.
View Article : Google Scholar
|
|
159
|
Wieser F, Fabjani G, Tempfer C,
Schneeberger C, Sator M, Huber J and Wenzl R: Analysis of an
interleukin-6 gene promoter polymorphism in women with
endometriosis by pyrosequencing. J Soc Gynecol Investig. 10:32–36.
2003.PubMed/NCBI
|
|
160
|
Schieffer B, Schieffer E, Hilfiker-Kleiner
D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W
and Drexler H: Expression of angiotensin II and interleukin 6 in
human coronary atherosclerotic plaques: Potential implications for
inflammation and plaque instability. Circulation. 101:1372–1378.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Moore KW, de Waal Malefyt R, Coffman RL
and O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu
Rev Immunol. 19:683–765. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Kitawaki J, Obayashi H, Ohta M, Kado N,
Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura
N, et al: Genetic contribution of the interleukin-10 promoter
polymorphism in endometriosis susceptibility. Am J Reprod Immunol.
47:12–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Zhang X, Hei P, Deng L and Lin J:
Interleukin-10 gene promoter polymorphisms and their protein
production in peritoneal fluid in patients with endometriosis. Mol
Hum Reprod. 13:135–140. 2007. View Article : Google Scholar
|
|
164
|
Tabrez S, Ali M, Jabir NR, Firoz CK,
Ashraf GM, Hindawi S, Damanhouri GA and Nabil Alama M: A putative
association of interleukin-10 promoter polymorphisms with
cardiovascular disease. IUBMB Life. 69:522–527. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Center DM, Kornfeld H and Cruikshank WW:
Interleukin-16. Int J Biochem Cell Biol. 29:1231–1234. 1997.
View Article : Google Scholar
|
|
166
|
Mathy NL, Scheuer W, Lanzendörfer M,
Honold K, Ambrosius D, Norley S, Kurth R, et al: Interleukin-16
stimulates the expression and production of pro-inflammatory
cytokines by human monocytes. Immunology. 100:63–69. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Cheong YC, Shelton JB, Laird SM, Richmond
M, Kudesia G, Li TC and Ledger WL: IL-1, IL-6 and TNF-alpha
concentrations in the peritoneal fluid of women with pelvic
adhesions. Hum Reprod. 17:69–75. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Watkins D and Rosenblatt DS: Inherited
disorders of folate and cobalamin transport and Metabolism. The
Online Metabolic and Molecular Bases of Inherited Disease. Valle
DL, Antonarakis S, Ballabio A, Beaudet AL and Mitchell GA:
McGraw-Hill Education; New York, NY: 2019
|
|
169
|
Lian Z, Lv FF, Yu J and Wang JW: The
anti-inflammatory effect of microRNA-383-3p interacting with IL1R2
against homocysteine-induced endothelial injury in rat coronary
arteries. J Cell Biochem. 119:6684–6694. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Cyster JG: Leukocyte migration: Scent of
the T zone. Curr Biol. 10:R30–R33. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Li G, Zhao J, Li B, Ma J, Zhao Q, Wang X,
Lv Z, Li K, Du Z, Ma X and Liu J: Associations between CCL21 gene
polymorphisms and susceptibility to rheumatoid arthritis: A
meta-analysis. Rheumatol Int. 37:1673–1681. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Damas JK, Smith C, Øie E, Fevang B,
Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A,
Ovchinnikova O, et al: Enhanced expression of the homeostatic
chemokines CCL19 and CCL21 in clinical and experimental
atherosclerosis: Possible pathogenic role in plaque
destabilization. Arterioscler Thromb Vasc Biol. 27:614–620. 2007.
View Article : Google Scholar
|
|
173
|
Nakayama T, Kitaya K, Okubo T, Kuroboshi
H, Daikoku N, Fushiki S and Honjo H: Fluctuation of 6Ckine
expression in human endometrium during the menstrual cycle. Fertil
Steril. 80:1461–1465. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Nilsson S and Gustafsson JA: Biological
role of estrogen and estrogen receptors. Crit Rev Biochem Mol Biol.
37:1–28. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Howard BV, Criqui MH, Curb JD, Rodabough
R, Safford MM, Santoro N, Wilson AC and Wylie-Rosett J: Risk factor
clustering in the insulin resistance syndrome and its relationship
to cardiovascular disease in postmenopausal white, black, hispanic,
and Asian/Pacific Islander women. Metabolism. 52:362–371. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Huang Q, Wang TH, Lu WS, Mu PW, Yang YF,
Liang WW, Li CX and Lin GP: Estrogen receptor alpha gene
polymorphism associated with type 2 diabetes mellitus and the serum
lipid concentration in Chinese women in Guangzhou. Chin Med J
(Engl). 119:1794–1801. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Lawlor DA, Timpson N, Ebrahim S, Day IN
and Smith GD: The association of oestrogen receptor
alpha-haplotypes with cardiovascular risk factors in the British
Women's Heart and Health Study. Eur Heart J. 27:1597–1604. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Almeida S and Hutz MH: Genetic variation
of estrogen metabolism and the risks of cardiovascular disease.
Curr Opin Investig Drugs. 8:814–820. 2007.PubMed/NCBI
|
|
179
|
Naccarati A, Polakova V, Pardini B,
Vodickova L, Hemminki K, Kumar R and Vodicka P: Mutations and
polymorphisms in TP53 gene-an overview on the role in colorectal
cancer. Mutagenesis. 27:211–218. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Bennett BJ, Davis RC, Civelek M, Orozco L,
Wu J, Qi H, Pan C, Packard RR, Eskin E, Yan M, et al: Genetic
Architecture of atherosclerosis in mice: A systems genetics
analysis of common inbred strains. PLoS Genet. 11:e10057112015.
View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Frank AK, Leu JI, Zhou Y, Devarajan K,
Nedelko T, Klein-Szanto A, Hollstein M and Murphy ME: The codon 72
polymorphism of p53 regulates interaction with NF-{kappa}B and
transactivation of genes involved in immunity and inflammation. Mol
Cell Biol. 31:1201–1213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Dumont C, Corsoni-Tadrzak A, Ruf S, de
Boer J, Williams A, Turner M, Kioussis D and Tybulewicz VL: Rac
GTPases play critical roles in early T-cell development. Blood.
113:3990–3998. 2009. View Article : Google Scholar :
|
|
183
|
Storry JR and Olsson ML: The ABO blood
group system revisited: A review and update. Immunohematology.
25:48–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Reilly MP, Li M, He J, Ferguson JF,
Stylianou IM, Mehta NN, Burnett MS, Devaney JM, Knouff CW, Thompson
JR, et al: Identification of ADAMTS7 as a novel locus for coronary
atherosclerosis and association of ABO with myocardial infarction
in the presence of coronary atherosclerosis: Two genome-wide
association studies. Lancet. 377:383–392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Pare G, Ridker PM, Rose L, Barbalic M,
Dupuis J, Dehghan A, Bis JC, Benjamin EJ, Shiffman D, Parker AN and
Chasman DI: Genome-wide association analysis of soluble ICAM-1
concentration reveals novel associations at the NFKBIK, PNPLA3,
RELA, and SH2B3 loci. PLoS Genet. 7:e10013742011. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Kiechl S, Pare G, Barbalic M, Qi L, Dupuis
J, Dehghan A, Bis JC, Laxton RC, Xiao Q, Bonora E, et al:
Association of variation at the ABO locus with circulating levels
of soluble intercellular adhesion molecule-1, soluble P-selectin,
and soluble E-selectin: A meta-analysis. Circ Cardiovasc Genet.
4:681–686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Roberts R and Stewart AF: 9p21 and the
genetic revolution for coronary artery disease. Clin Chem.
58:104–112. 2012. View Article : Google Scholar
|
|
188
|
Broadbent HM, Peden JF, Lorkowski S, Goel
A, Ongen H, Green F, Clarke R, Collins R, Franzosi MG, Tognoni G,
et al: Susceptibility to coronary artery disease and diabetes is
encoded by distinct, tightly linked SNPs in the ANRIL locus on
chromosome 9p. Hum Mol Genet. 17:806–814. 2008. View Article : Google Scholar
|
|
189
|
Cunnington MS, Santibanez Koref M, Mayosi
BM, Burn J and Keavney B: Chromosome 9p21 SNPs associated with
multiple disease phenotypes correlate with ANRIL expression. PLoS
Genet. 6:e10008992010. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Kalpana B, Murthy DK and Balakrishna N:
9p213 coronary artery disease risk locus and interferon alpha 21:
Association study in an Asian Indian population. Indian Heart J.
71:476–480. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Lee GH, Choi YM, Hong MA, Yoon SH, Kim JJ,
Hwang K and Chae SJ: Association of CDKN2B-AS and WNT4 genetic
polymorphisms in Korean patients with endometriosis. Fertil Steril.
102:1393–1397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Motterle A, Pu X, Wood H, Xiao Q, Gor S,
Ng FL, Chan K, Cross F, Shohreh B, Poston RN, et al: Functional
analyses of coronary artery disease associated variation on
chromosome 9p21 in vascular smooth muscle cells. Hum Mol Genet.
21:4021–4029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Boettger T, Beetz N, Kostin S, Schneider
J, Krüger M, Hein L and Braun T: Acquisition of the contractile
phenotype by murine arterial smooth muscle cells depends on the
Mir143/145 gene cluster. J Clin Invest. 119:2634–2647. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Cordes KR, Sheehy NT, White MP, Berry EC,
Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Elia L, Quintavalle M, Zhang J, Contu R,
Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J,
et al: The knockout of miR-143 and -145 alters smooth muscle cell
maintenance and vascular homeostasis in mice: Correlates with human
disease. Cell Death Differ. 16:1590–1598. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Elia L, Kunderfranco P, Carullo P,
Vacchiano M, Farina FM, Hall IF, Mantero S, Panico C, Papait R,
Condorelli G and Quintavalle M: UHRF1 epigenetically orchestrates
smooth muscle cell plasticity in arterial disease. J Clin Invest.
128:2473–2486. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Xin M, Small EM, Sutherland LB, Qi X,
McAnally J, Plato CF, Richardson JA, Bassel-Duby R and Olson EN:
MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and
responsiveness of smooth muscle cells to injury. Genes Dev.
23:2166–2178. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Quintavalle M, Elia L, Condorelli G and
Courtneidge SA: MicroRNA control of podosome formation in vascular
smooth muscle cells in vivo and in vitro. J Cell Biol. 189:13–22.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Climent M, Quintavalle M, Miragoli M, Chen
J, Condorelli G and Elia L: TGFβ Triggers miR-143/145 transfer from
smooth muscle cells to endothelial cells, thereby modulating vessel
stabilization. Circ Res. 116:1753–1764. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Faccini J, Ruidavets JB, Cordelier P,
Martins F, Maoret JJ, Bongard V, Ferrières J, Roncalli J, Elbaz M
and Vindis C: Circulating miR-155, miR-145 and let-7c as diagnostic
biomarkers of the coronary artery disease. Sci Rep. 7:429162017.
View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Hall IF, Climent M, Viviani Anselmi C,
Papa L, Tragante V, Lambroia L, Farina FM, Kleber ME, März W,
Biguori C, et al: rs41291957 controls miR-143 and miR-145
expression and impacts coronary artery disease risk. EMBO Mol Med.
13:e140602021. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Nimi-Hoveidi E, Kohan L and Hashemi SS:
Association of miR-143 rs41291957 and rs4705342 genetic variants
with endometriosis risk in infertile women. Feyz J Kashan Univ Med
Sci. 20:441–446. 2016.
|
|
203
|
Bashti O, Noruzinia M, Garshasbi M and
Abtahi M: miR-31 and miR-145 as potential non-invasive regulatory
biomarkers in patients with endometriosis. Cell J. 20:84–89.
2018.PubMed/NCBI
|
|
204
|
Ounzain S, Micheletti R, Arnan C,
Plaisance I, Cecchi D, Schroen B, Reverter F, Alexanian M, Gonzales
C, Ng SY, et al: CARMEN, a human super enhancer-associated long
noncoding RNA controlling cardiac specification, differentiation
and homeostasis. J Mol Cell Cardiol. 89:98–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Plaisance I, Perruchoud S,
Fernandez-Tenorio M, Gonzales C, Ounzain S, Ruchat P, Nemir M,
Niggli E and Pedrazzini T: Cardiomyocyte lineage specification in
adult human cardiac precursor cells via modulation of
enhancer-associated long noncoding RNA expression. JACC Basic
Transl Sci. 1:472–493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu
Q, Deitch EA, Huo Y, Delphin ES and Zhang C: MicroRNA-145, a novel
smooth muscle cell phenotypic marker and modulator, controls
vascular neointimal lesion formation. Circ Res. 105:158–166. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Wang X, Hu G and Zhou J: Repression of
versican expression by microRNA-143. J Biol Chem. 285:23241–23250.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Dong K, Shen J, He X, Hu G, Wang L, Osman
I, Bunting KM, Dixon-Melvin R, Zheng Z, Xin H, et al: CARMN is an
evolutionarily conserved smooth muscle cell-specific LncRNA that
maintains contractile phenotype by binding myocardin. Circulation.
144:1856–1875. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Li M, Wang J, Fang Y, Gong S, Li M, Wu M,
Lai X, Zeng G, Wang Y, Yang K and Huang X: microRNA-146a promotes
mycobacterial survival in macrophages through suppressing nitric
oxide production. Sci Rep. 6:233512016. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Sidorkiewicz M, Grek M, Jozwiak B, Krol A
and Piekarska A: The impact of chronic hepatitis C infection on
cholesterol metabolism in PBMCs is associated with microRNA-146a
expression. Eur J Clin Microbiol Infect Dis. 36:697–702. 2017.
View Article : Google Scholar
|
|
211
|
Takahashi Y, Satoh M, Minami Y, Tabuchi T,
Itoh T and Nakamura M: Expression of miR-146a/b is associated with
the Toll-like receptor 4 signal in coronary artery disease: Effect
of renin-angiotensin system blockade and statins on miRNA-146a/b
and Toll-like receptor 4 levels. Clin Sci. 119:395–405. 2010.
View Article : Google Scholar
|
|
212
|
Gangwar RS, Rajagopalan S, Natarajan R and
Deiuliis JA: Noncoding RNAs in cardiovascular disease: Pathological
relevance and emerging role as biomarkers and therapeutics. Am J
Hypertens. 31:150–165. 2018. View Article : Google Scholar :
|
|
213
|
Zhou L, Zhao X, Han Y, Lu Y, Shang Y, Liu
C, Li T, Jin Z, Fan D and Wu K: Regulation of UHRF1 by miR-146a/b
modulates gastric cancer invasion and metastasis. FASEB J.
27:4929–4939. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Ramirez-Moya J, Wert-Lamas L and
Santisteban P: MicroRNA-146b promotes PI3K/AKT pathway
hyperactivation and thyroid cancer progression by targeting PTEN.
Oncogene. 37:3369–3383. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Zhu Y, Wu G, Yan W, Zhan H and Sun P:
miR-146b-5p regulates cell growth, invasion, and metabolism by
targeting PDHB in colorectal cancer. Am J Cancer Res. 7:1136–1150.
2017.PubMed/NCBI
|
|
216
|
Jin H, Zhang H, Ma T, Lan H, Feng S, Zhu H
and Ji Y: Resveratrol protects murine chondrogenic ATDC5 cells
against LPS-induced inflammatory injury through Up-regulating
MiR-146b. Cell Physiol Biochem. 47:972–980. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Gao S, Zhao Z, Wu R, Wu L, Tian X and
Zhang Z: MiR-146b inhibits autophagy in prostate cancer by
targeting the PTEN/Akt/mTOR signaling pathway. Aging. 10:2113–2121.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Curtale G, Mirolo M, Renzi TA, Rossato M,
Bazzoni F and Locati M: Negative regulation of Toll-like receptor 4
signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA.
110:11499–11504. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: The role of miR-126 in embryonic angiogenesis, adult vascular
homeostasis, and vascular repair and its alterations in
atherosclerotic disease. J Mol Cell Cardiol. 97:47–55. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Urbich C, Kaluza D, Frömel T, Knau A,
Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN,
Hergenreider E, et al: MicroRNA-27a/b controls endothelial cell
repulsion and angiogenesis by targeting semaphorin 6A. Blood.
119:1607–1616. 2012. View Article : Google Scholar
|
|
221
|
Su X, Hu Y, Li Y, Cao JL, Wang XQ, Ma X
and Xia HF: The polymorphism of rs6505162 in the MIR423 coding
region and recurrent pregnancy loss. Reproduction. 150:65–76. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Medford HM and Marsh SA: The role of
O-GlcNAc transferase in regulating the gene transcription of
developing and failing hearts. Future Cardiol. 10:801–812. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Luo P, He T, Jiang R and Li G:
MicroRNA-423-5p targets O-GlcNAc transferase to induce apoptosis in
cardiomyocytes. Mol Med Rep. 12:1163–1168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Amin MMJ, Trevelyan CJ and Turner NA:
MicroRNA-214 in health and disease. Cells. 10:32742021. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Taskin O, Rikhraj K, Tan J, Sedlak T, Rowe
TC and Bedaiwy MA: Link between Endometriosis, Atherosclerotic
Cardiovascular Disease, and the Health of Women Midlife. J Minim
Invasive Gynecol. 26:781–784. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
226
|
Missmer SA: Commentary:
Endometriosis-epidemiologic considerations for a potentially
'high-risk' population. Int J Epidemiol. 38:1154–1155. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
227
|
O'Sullivan JW, Raghavan S, Marquez-Luna C,
Luzum JA, Damrauer SM, Ashley EA, O'Donnell CJ, Willer CJ and
Natarajan P; American Heart Association Council on Genomic and
Precision Medicine; et al Polygenic risk scores for cardiovascular
disease: A scientific statement from the American Heart
Association. Circulation. 146. pp. e93–e118. 2022
|
|
228
|
Bulun SE, Monsavais D, Pavone ME, Dyson M,
Xue Q, Attar E, Tokunaga H and Su EJ: Role of estrogen receptor-β
in endometriosis. Semin Reprod Med. 30:39–45. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Stevenson JC: Long-term benefits and risks
of HRT (Section 11): Cardiovascular disease. Post Reprod Health.
22:80–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Newson L: Menopause and cardiovascular
disease. Post Reprod Health. 24:44–49. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Patel BG, Lenk EE, Lebovic DI, Shu Y, Yu J
and Taylor RN: Pathogenesis of endometriosis: Interaction between
Endocrine and inflammatory pathways. Best Pract Res Clin Obstet
Gynaecol. 50:50–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
